INTRODUCTION
============

Cytosine methylation at CpG sites in the genomic DNA is a well-characterized epigenetic modification involved in gene regulation and transposon silencing in mammals ([@gks1117-B1],[@gks1117-B2]). Upon replication of methylated DNA, cytosines in the newly synthesized strand are initially unmethylated (resulting in a hemimethylated duplex), then become methylated by a maintenance-type DNA methylase, Dnmt1. In addition, the *de novo* DNA methylases, Dnmt3a and Dnmt3b, also have a role in the maintenance methylation for some genomic regions ([@gks1117-B3; @gks1117-B4; @gks1117-B5]). Due to this template-dependent copying mechanism, the pattern of CpG methylation is essentially heritable in somatic cells through cell division.

In contrast, the level of DNA methylation changes dynamically during germ-cell development. First, primordial germ cells (PGCs) undergo genome-wide erasure of methylation and then prospermatogonia, a direct derivative of PGCs in the male gonad, undergo extensive *de novo* methylation ([@gks1117-B6],[@gks1117-B7]) ([Figure 1](#gks1117-F1){ref-type="fig"}A). The prospermatogonia are mitotically arrested, premeiotic cells expressing high levels of the *de novo* DNA methylase Dnmt3a and its related protein Dnmt3l ([@gks1117-B8],[@gks1117-B9]). They resume mitotic division for cell expansion and spermatogonial differentiation after birth. Therefore, *de novo* DNA methylation and its maintenance through cell division can be separately observed in these germ cells. Oocytes are also non-dividing cells that undergo extensive *de novo* methylation ([@gks1117-B6],[@gks1117-B7]), but the methylation marks in most genomic regions are not maintained through cell divisions after fertilization ([@gks1117-B10]). Figure 1.Non-CpG methylation at B1 retrotransposon loci in neonatal prospermatogonia. (**A**) Chronology of male germ-cell development from PGCs to spermatogonia. Mitotically arrested prospermatogonia undergo *de novo* methylation of CpG sites in the fetal testis, and mitosis resumes after birth. (**B**). Non-CpG methylation at three representative B1 loci detected by bisulfite sequencing in P0 prospermatogonia (see [Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gks1117/DC1) for other loci). Circles and squares represent cytosines in CpG and non-CpG (CpH where H is A, T or C) sites, respectively. The methylated cytosines are shown in black for CpG and in gray for CpH. (**C**) Alignment of the sequences of the 33 B1 loci to visualize the common sites of methylation. Cytosines methylated over 65% at CpG sites are highlighted in black, and those methylated over 5% at non-CpG sites are highlighted in gray. Positions of A- and B-box in the Pol III promoter and the binding sites for the AhR and Slug transcription factors are indicated above. (**D**) Methylation levels in different sequence contexts. The data for dinucleotides and trinucleotides are shown. (**E**) Individual CpG and non-CpG sites are categorized according to their methylation levels, and counted.

Short interspersed elements (SINEs) are a class of retrotransposons and are transcribed by RNA plolymerase III (Pol III). Biochemical studies have shown that CpG methylation of the Pol III promoter inhibits transcription of tRNAs and human *Alu* SINE ([@gks1117-B11; @gks1117-B12; @gks1117-B13]). We previously showed that the bulk of CpG sites in B1 retrotransposons, a family of SINEs scattered over the mouse genome, become highly methylated in prospermatogonia and stay methylated throughout the later stages of spermatogenesis ([@gks1117-B14]). We also showed that a mutation in *Dnmt3a* or *Dnmt3l* reduces the methylation levels in a locus-specific manner and that the level of B1 methylation is well correlated with the level of B1 expression ([@gks1117-B14]). During the course of that study, we noticed that methylation at non-CpG sites is abundantly present in prospermatogonia. This is interesting because non-CpG methylation has been so far found in oocytes, embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs) and the brain ([@gks1117-B3],[@gks1117-B15; @gks1117-B16; @gks1117-B17; @gks1117-B18; @gks1117-B19; @gks1117-B20; @gks1117-B21]). Although non-CpG methylation dramatically decreases upon differentiation of ESCs and thus could have some relevance to pluripotency ([@gks1117-B3],[@gks1117-B19]), the biological function of non-CpG methylation remains unknown. In this report, we characterize the non-CpG methylation that we found at B1 retrotransposons in prospermatogonia in detail. We show accumulation of the non-CpG methylation in the non-dividing prospermatogonia and its gradual loss after the resumption of cell division. We also provide evidence suggesting the absence of a template-dependent copying mechanism for non-CpG methylation.

MATERIALS AND METHODS
=====================

Cell preparation and bisulfite-PCR sequencing
---------------------------------------------

EpCAM-positive germ cells were collected from testes of C57BL/6 J mice at P0, P2, P5 and P7 as described previously ([@gks1117-B14]). To collect fetal germ cells at E16.5, green fluorescent protein (GFP)-positive cells were sorted from the testes of Oct4-GFP transgenic embryos. Genomic DNA preparation, bisulfite conversion and PCR were done as described previously ([@gks1117-B14]). Typically, 100--200 ng of genomic DNA was treated with bisulfite, and an aliquot equivalent to 5--10 ng of genomic DNA was used for PCR with ExTaq HS (TAKARA BIO, Ohtsu, Japan). To monitor the efficiency of C-to-T conversion, λ phage DNA that had no methylated cytosine (Promega, Madison, WI) was included in the bisulfite reaction. All sequenced clones were used for the analysis. To validate the purity of germ-cell preparations, methylation of the imprinted *Lit1* differentially methylated region (DMR) was also analysed using the same bisulfite-treated DNA. Among at least 40 sequenced clones, none showed methylation in the *Lit1* DMR, suggesting a germ-cell purity of \>95%, given that only the maternal *Lit1* DMR allele is methylated in somatic cells and no allele is methylated in male germ cells. Bisulfite PCR primers for the 33 B1 loci were previously described ([@gks1117-B14]). The sequences of the primers for the DMRs, CpG islands and control λ phage DNA are shown in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gks1117/DC1).

Hairpin-bisulfite PCR analysis
------------------------------

Genomic DNA (100 ng) was digested with *Taqα*I (New England Biolab, Ipswich, MA) and ligated with a synthetic oligonucleotide (5\'-CGTGAACTGAGGTCGGAAGACCTCAGTTCA-3\') that forms a hairpin structure. The ligation product was denatured at 98°C for 10 min in 0.3 M NaOH, treated with 9.17 M bisulfite ([@gks1117-B22]) and used for PCR as described ([@gks1117-B14]). The hairpin-bisulfite PCR primers for the three B1 loci are listed in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gks1117/DC1).

RESULTS AND DISCUSSION
======================

We collected prospermatogonia at postnatal day 0 (P0) and studied DNA methylation states of 33 B1 loci by bisulfite sequencing. The bisulfite sequencing method is unable to distinguish between 5-methylcytosine (5mC) and 5-hydroxylmethylcytosine (5hmC), but hereinafter we regard bisulfite-resistant cytosines as 5mC, given that 5hmC is present much less than 5mC in cells/tissues examined so far, and almost exclusively at CpG sites in ESCs ([@gks1117-B23]). As shown in [Figure 1](#gks1117-F1){ref-type="fig"}B, C and [Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gks1117/DC1), significant methylation was found at non-CpG sites, in addition to CpG sites, both within and around the B1 sequences. This was not due to imcomplete bisulfite conversion, because the failure rate was only 0.2--0.5%, as determined using the control unmethylated DNA (λ phage DNA) mixed to the samples. On average, the methylation level at non-CpG sites (total of ∼2700) in P0 prospermatogonia was 4.8%, which was higher than the levels in ESCs (2.6%), iPSCs (3.2%), oocytes (3.4--3.8%) and the brain (1.5--2.2%) ([@gks1117-B16],[@gks1117-B20],[@gks1117-B21]). Of all methylated cytosines, 77% were at CpG sites and 23% were at non-CpG sites. When the methylation level was determined for each dinucleotide sequence, it was 94%, 9.8%, 1.3% and 0.4% at CpG, CpA, CpT and CpC sites, respectively ([Figure 1](#gks1117-F1){ref-type="fig"}D). About half of CpA sites showed methylation levels of higher than 5%, whereas the vast majority of CpT and CpC sites showed no methylation ([Figure 1](#gks1117-F1){ref-type="fig"}E). Thus, CpA is the most preferred non-CpG sites. Among the CpA sites, the CpApC (15%) and CpApG sites (12%) were more frequently methylated than the CpApA and CpApT sites ([Figure 1](#gks1117-F1){ref-type="fig"}D). Interestingly, despite that the 33 B1 loci that we analysed were from various genomic locations, some non-CpG sites at equivalent positions in the B1 sequences were more preferentially methylated ([Figure 1](#gks1117-F1){ref-type="fig"}C). A subfamily of B1 sequences, designated as B1-X35S, has been shown to bind the AhR and Slug transcription factors, and the binding was involved in the formation of a chromatin boundary ([@gks1117-B24],[@gks1117-B25]). However, the preferentially methylated non-CpG sites did not overlap with these binding sites or the RNA Polymerase III promoter (A-box and B-box) ([Figure 1](#gks1117-F1){ref-type="fig"}C).

To address whether the non-CpG methylation is specific to B1 sequences or not, we examined the methylation status of three paternally methylated DMRs (the *H19*, *Dlk1*/*Meg3* and *Rasgrf1* DMRs) in P0 prospermatogonia. Non-CpG methylation was detected in the DMRs with the levels comparable to those in B1 loci ([Supplementary Figure S2A](http://nar.oxfordjournals.org/cgi/content/full/gks1117/DC1)). We also examined seven CpG islands that are methylated in spermatozoa ([@gks1117-B26]). Whereas three of them were not methylated even at CpG sites (data not shown), the other four had methylation at non-CpG sites in P0 prospermatogonia ([Supplementary Figure S2B](http://nar.oxfordjournals.org/cgi/content/full/gks1117/DC1)). These results suggest that non-CpG methylation is widespread in the prospermatogonia.

It is known that *de novo* CpG methylation of the DMRs and retrotransposons occurs in prospermatogonia between embryonic day 14.5 (E14.5) and P0 ([@gks1117-B27]). The presence of non-CpG methylation in P0 prospermatogonia suggested their co-occurence with CpG methylation in fetal prospermatogonia. We selected eight B1 loci that showed high levels of non-CpG methylation in P0 prospermtogonia (B1_007, B1_014, B1_016, B1_018, B1_021, B1_042, B1_045 and B1_055) ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gks1117/DC1)) and examined their methylation status in prospermatogonia at embryonic day 16.5 (E16.5) ([Figure 2](#gks1117-F2){ref-type="fig"}A and C). The average CpA methylation level at E16.5 was six times less than that at P0, indicating that these non-CpG sites become *de novo* methylated in prospermatogonia during late gestation. In the same period, the methylation level at CpG sites increased four times. We previously showed that mutation in *Dnmt3a* or *Dnmt3l* affects CpG methylation at B1 loci ([@gks1117-B14]). We therefore analysed P0 prospermatogonia from *Dnmt3l* knockout mice ([@gks1117-B28]) for the eight loci ([Figure 2](#gks1117-F2){ref-type="fig"}B). The CpA methylation level was significantly reduced (\>5-fold, *P* \< 10^−13^) by the *Dnmt3l* mutation ([Figure 2](#gks1117-F2){ref-type="fig"}B and C), suggesting that the non-CpG methylation in prospermatogonia is dependent on *Dnmt3l*. Figure 2.*De novo* methylation of non-CpG sites occurs concomitantly with *de novo* CpG methylation. (**A**) Site-by-site representation of the bisulfite sequencing data for the eight selected B1 loci in E16.5 prospermatogonia. (**B**) Methylation status of the same B1 loci in Dnmt3l knockout (KO) P0 prospermatogonia. (**C**) Methylation levels of cytosines at B1 loci in each sequence context.

It is known that higher plants have methylation at both CpHpG and CpHpH sites (where H = A, C or T) ([@gks1117-B2]). At CpHpG sites, the two cytosines on the different DNA strands are symmetrically methylated ([@gks1117-B29],[@gks1117-B30]), and the chromo-methylase CMT3 is responsible for this methylation ([@gks1117-B31],[@gks1117-B32]). A previous study in human ESCs and iPSCs showed that the levels of methylation at given CpHpG sites differ between the two strands ([@gks1117-B19]), consistent with the fact that no CMT3-like methylase is found in mammals. However, in that study, the bisulfite reads were from different DNA duplexes and the read numbers were small. Therefore, whether the CpHpG sites are indeed hemimethylated in the same duplex has been an open question. To address this issue, we used the hairpin-bisulfite sequencing method ([@gks1117-B33]) with some modifications ([Figure 3](#gks1117-F3){ref-type="fig"}A). Briefly, genomic DNA was digested with *Taq*I, ligated to synthetic hairpin forming DNA, and subjected to bisulfite reaction followed by PCR. The PCR primers were designed so that the amplicon consisted of the top- and bottom-strand sequences from a single duplex separated by the hairpin DNA sequence. The results obtained from three B1 loci showed that 87.5% of CpG sites were symmetrically methylated in P0 prospermatogonia ([Figure 3](#gks1117-F3){ref-type="fig"}B and C). In contrast, we detected no symmetric methylation at any CAG or CTG sites (the cumulative number of tested sites was 69) ([Figure 3](#gks1117-F3){ref-type="fig"}B and C). This suggests that a template-dependent copying mechanism does not operate in methylation at CpHpG sites. Thus, most or all of non-CpG methylation is ascribed to *de novo* methylation. The dinucleotide preference observed at the non-CpG sites (CpA\>CpT\>CpC) in prospermatogonia is well correlated with the target preference of the recombinant Dnmt3a protein ([@gks1117-B34],[@gks1117-B35]). Indeed, in human and mouse ESCs and mouse oocytes, a depletion of the *de novo* methylases resulted in greatly reduced non-CpG methylation (3,17,18,20, K. Shirane *et al.* submitted for publication). Figure 3.Asymmetric methylation at CpHpG sites. (**A**) Procedure for hairpin-bisulfite sequencing. (**B**) Examples of the reads obtained by hairpin-bisulfite sequencing. (**C**) Results of hairpin-bisulfite sequencing of three B1 loci. The numbers of sites with symmetric or asymmetric methylation are shown for CAG (and CTG) and CG sites. Methylated cytosines are highlighted.

Next, we studied the fate of non-CpG methylation after birth, during the transition from the prospermatogonia to spermatogonia. The mitotically arrested prospermatogonia resume mitotic cell division at this stage. Proliferating spermatogonia at P7 showed very low levels of methylation at all three non-CpG dinucleotides (0.2--0.4%) ([Figure 1](#gks1117-F1){ref-type="fig"}D), which were comparable to the error rate of bisulfite conversion (0.2--0.5%). This suggests that non-CpG methylation decreases along with mitotic divisions. We then studied the time course of the loss of non-CpG methylation between P0 and P7. Whereas the CpG methylation levels in the 33 B1 loci stayed around 95% at all time points, the non-CpG methylation levels declined gradually ([Figure 4](#gks1117-F4){ref-type="fig"}A and [Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gks1117/DC1)). For example, the average CpA methylation levels were 9.8, 7.4, 1.5 and 0.4% at P0, P2, P5 and P7, respectively ([Figure 4](#gks1117-F4){ref-type="fig"}B). These results suggest that the *de novo* methylation activity is not high in postnatal germ cells and that the lack of a copying mechanism for non-CpG methylation results in a gradual loss of this methylation after every DNA replication. The *Dnmt3a* and *Dnmt3l* expression levels are high in prospermatogonia but become low after birth, and the *Dnmt3b* expression level is relatively low in prospermatogonia ([@gks1117-B8],[@gks1117-B9]). Figure 4.Loss of non-CpG methylation after the resumption of mitosis in postnatal development. (**A**) Gradual loss of methylation at a representative B1 locus in the transition period from prospermatogonia to spermatogonia (P0, P2, P5 and P7). CpG sites are shown in circles and non-CpG sites are shown in squares, with open and filled (black or gray) symbols representing unmethylated and methylated cytosines, respectively. (**B**) Methylation levels of the 33 B1 loci at CpG sites and CpA sites at P0, P2, P5 and P7. The boxes indicate 75 and 25 percentiles, with the thick line inside being the median. The ends of the wiskers represent 95 and 5 percentiles. The dashed line indicates the average.

Since a high level of non-CpG methylation was first detected in pluripotent cells such as ESCs and iPSCs, a correlation of non-CpG methylation with pluripotency has been discussed ([@gks1117-B19]). However, the detection of non-CpG methylation in oocytes, brain cells and prospermatogonia suggests that the above may not be the case. Rather, the feature common to these cell types seems relatively high expression levels of the *de novo* methylase(s) ([@gks1117-B6],[@gks1117-B7],[@gks1117-B36],[@gks1117-B37]). Indeed, in human ESCs and iPSCs, the level of non-CpG methylation is better correlated with the expression levels of the *de novo* methylases than those of pluripotency factors ([@gks1117-B20]).

In summary, we showed that non-CpG methylation accumulates within and around B1 SINE sequences, as well as the paternally methylated DMRs and some CpG islands, in the mitotically arrested prospermatogonia during fetal development. The observed non-CpG methylation level was relatively high compared with other cells, but this does not necessarily mean that prospermatogonia have high levels of non-CpG methylation throughout the genome, as non-CpG methylation is relatively high in the *Alu* SINE sequences in human ESCs ([@gks1117-B20]). Our hairpin-bisulfite sequencing revealed that non-CpG sites including symmetrical CpHpG sites are hemimethylated. Therefore, it appears that no template-dependent copying mechanism exsists for non-CpG methylation in prospermatogonia. Rather, almost all non-CpG methylation is ascribed to *de novo* methylation. Perhaps, the presence and the level of non-CpG methylation are determined by the balance between the *de novo* methylation activity and the rate of cell proliferation. In the case of B1 retrotransposons, the non-CpG methylation may not have a role in regulation of transcription or boundary function as shown above, but further studies are needed to know whether non-CpG methylation in other genomic regions has a function.
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